Inserm is involved in partnerships with private players in the field of research and has strong partnerships with national and international industrial companies including Dassault Systèmes, MSD Avenir, MedImmune/AstraZeneca, Sanofi and Pierre Fabre.

Partnerships between Inserm and industry rely on the know-how of Inserm Transfert. This private subsidiary of Inserm manages the implementation and transfer of knowledge from Inserm's research laboratories to industry, helping to promote health innovation.

Industrial partnerships: 2016 figures

  • 62 license agreements signed during the year
  • 229 R&D agreements signed during the year
  • €31,40 million in revenue from industrial partnerships